Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,416 | -34,803 | -27,354 | -19,563 | -10,102 |
| Depreciation Amortization | 288 | 1,267 | 962 | 647 | 326 |
| Accounts receivable | 255 | -236 | -527 | -386 | -125 |
| Accounts payable and accrued liabilities | -68 | -707 | -719 | -694 | -613 |
| Other Working Capital | -1,171 | -2,245 | -2,454 | -2,236 | -2,929 |
| Other Operating Activity | 1,090 | 7,867 | 6,846 | 5,430 | 2,790 |
| Operating Cash Flow | $-7,022 | $-28,857 | $-23,246 | $-16,802 | $-10,653 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2 | -222 | -90 | -56 | -11 |
| Purchase Sale Intangibles | N/A | -70 | -70 | -70 | -70 |
| Other Investing Activity | 0 | -70 | -70 | -70 | -70 |
| Investing Cash Flow | $2 | $-292 | $-160 | $-126 | $-81 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,010 | 10,207 | 8,069 | 4,960 | 2,964 |
| Other Financing Activity | -103 | -94 | -74 | -51 | -7 |
| Financing Cash Flow | $2,907 | $10,113 | $7,995 | $4,909 | $2,957 |
| Exchange Rate Effect | N/A | 11 | -2 | N/A | N/A |
| Beginning Cash Position | 43,853 | 62,878 | 62,878 | 62,878 | 62,878 |
| End Cash Position | 39,740 | 43,853 | 47,465 | 50,859 | 55,101 |
| Net Cash Flow | $-4,113 | $-19,025 | $-15,413 | $-12,019 | $-7,777 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,022 | -28,857 | -23,246 | -16,802 | -10,653 |
| Capital Expenditure | N/A | -226 | -90 | -56 | -11 |
| Free Cash Flow | -7,022 | -29,083 | -23,336 | -16,858 | -10,664 |